Two major multiprotein complexes comprise mTOR (mTORC1 and mTORC2) and rapamycin, and its chemically-related compounds (also known as rapalogues) were used in clinical trials for the treatment of GBM. This evidence concerns the gene MTOR and glioblastoma.